Pharmamarketeer

AstraZeneca announces positive results from phase III ETHOS trial of triple-combo therapy Breztri Aerosphere to treat COPD

AstraZeneca announced positive results from the phase III ETHOS trial for triple─combination therapy Breztri Aerosphere, formerly PT010, in patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

Medhc-fases-banner
Advertentie(s)